» Articles » PMID: 27242166

Human T Cell Responses to Japanese Encephalitis Virus in Health and Disease

Abstract

Japanese encephalitis (JE) virus (JEV) is an important cause of encephalitis in children of South and Southeast Asia. However, the majority of individuals exposed to JEV only develop mild symptoms associated with long-lasting adaptive immunity. The related flavivirus dengue virus (DENV) cocirculates in many JEV-endemic areas, and clinical data suggest cross-protection between DENV and JEV. To address the role of T cell responses in protection against JEV, we conducted the first full-breadth analysis of the human memory T cell response using a synthetic peptide library. Ex vivo interferon-γ (IFN-γ) responses to JEV in healthy JEV-exposed donors were mostly CD8(+) and targeted nonstructural (NS) proteins, whereas IFN-γ responses in recovered JE patients were mostly CD4(+) and targeted structural proteins and the secreted protein NS1. Among patients, a high quality, polyfunctional CD4(+) T cell response was associated with complete recovery from JE. T cell responses from healthy donors showed a high degree of cross-reactivity to DENV that was less apparent in recovered JE patients despite equal exposure. These data reveal divergent functional CD4(+) and CD8(+) T cell responses linked to different clinical outcomes of JEV infection, associated with distinct targeting and broad flavivirus cross-reactivity including epitopes from DENV, West Nile, and Zika virus.

Citing Articles

Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort.

Wullimann D, Sandberg J, Akber M, Lofling M, Gredmark-Russ S, Michaelsson J PLoS Negl Trop Dis. 2025; 19(2):e0012693.

PMID: 40019865 PMC: 11893121. DOI: 10.1371/journal.pntd.0012693.


Myeloid-Derived Suppressor Cells Induce Exhaustion-Like CD8 T Cells during JEV Infection.

Zhang W, Yu Q, Gao X, Chen H, Su J, Chen Y Int J Biol Sci. 2024; 20(15):5959-5978.

PMID: 39664572 PMC: 11628328. DOI: 10.7150/ijbs.102372.


Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity.

Aregay A, Slunecko J, Bogovic P, Korva M, Rus K, Knap N Emerg Microbes Infect. 2024; 13(1):2317909.

PMID: 39133062 PMC: 10883091. DOI: 10.1080/22221751.2024.2317909.


Regional Variation of the CD4 and CD8 T Cell Epitopes Conserved in Circulating Dengue Viruses and Shared with Potential Vaccine Candidates.

Chawla Y, Bajpai P, Saini K, Reddy E, Patel A, Murali-Krishna K Viruses. 2024; 16(5).

PMID: 38793612 PMC: 11126086. DOI: 10.3390/v16050730.


Pilot Study on Evaluating the Impact of Tetanus, Diphtheria, and Pertussis (Tdap), Influenza, and COVID-19 Vaccinations on Antibody Responses in Pregnant Women.

Chen W, Hu S, Cheng C, Shen C, Chuang H, Ker C Vaccines (Basel). 2024; 12(3).

PMID: 38543946 PMC: 10974830. DOI: 10.3390/vaccines12030312.


References
1.
Van Gessel Y, Klade C, Putnak R, Formica A, Krasaesub S, Spruth M . Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers. Vaccine. 2011; 29(35):5925-31. DOI: 10.1016/j.vaccine.2011.06.062. View

2.
Akondy R, Monson N, Miller J, Edupuganti S, Teuwen D, Wu H . The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol. 2009; 183(12):7919-30. PMC: 3374958. DOI: 10.4049/jimmunol.0803903. View

3.
Larena M, Regner M, Lobigs M . Cytolytic effector pathways and IFN-γ help protect against Japanese encephalitis. Eur J Immunol. 2013; 43(7):1789-98. DOI: 10.1002/eji.201243152. View

4.
Solomon T, Dung N, Kneen R, Thao L, Gainsborough M, Nisalak A . Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain. 2002; 125(Pt 5):1084-93. DOI: 10.1093/brain/awf116. View

5.
Draenert R, Altfeld M, Brander C, Basgoz N, Corcoran C, Wurcel A . Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. J Immunol Methods. 2003; 275(1-2):19-29. DOI: 10.1016/s0022-1759(02)00541-0. View